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NMR study of complexes between low molecular mass inhibitors and the West 
Nile virus NS2B-NS3 protease 
Abstract 
The two-component NS2B-NS3 protease of West Nile virus is essential for its replication and presents an 
attractive target for drug development. Here, we describe protocols for the high-yield expression of stable 
isotope-labelled samples in vivo and in vitro. We also describe the use of NMR spectroscopy to determine 
the binding mode of new low molecular mass inhibitors of the West Nile virus NS2B-NS3 protease which 
were discovered using high-throughput in vitro screening. Binding to the substrate-binding sites S1 and S3 
is confirmed by intermolecular NOEs and comparison with the binding mode of a previously identified low 
molecular mass inhibitor. Our results show that all these inhibitors act by occupying the substrate-binding 
site of the protease rather than by an allosteric mechanism. In addition, the NS2B polypeptide chain was 
found to be positioned near the substrate-binding site, as observed previously in crystal structures of the 
protease in complex with peptide inhibitors or bovine pancreatic trypsin inhibitor. This indicates that the 
new low molecular mass compounds, although inhibiting the protease, also promote the proteolytically 
active conformation of NS2B, which is very different from the crystal structure of the protein without 
inhibitor. 
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1131 5'-PO4-TTAGCTGGTCGATCCCGCGAAATTAATACG-3' (30-mer) 
1132 5'-PO4-CCAGCTAACAAAAAACCCCTCAAGACCCG-3' (29-mer) 
1133  5'-PO4-TCGATCCCGCGAAATTAATACG-3' (22-mer)  




     CACCATCACACAGACATGTGGATTGAGAGG-3’ (68-mer) 
1308
2
 5’- TTTGAATTCTTATTTCTTCCTCAACATTTCAGGTTCGAAGCC-3’ (42-mer)   
13143 5’-GTGATTGGATTGTATGCGAACGGCGTCATC-3’ (30-mer) 
13153 5’-GATGACGCCGTTCGCATACAATCCAATCAC-3’ (30-mer) 
 
1
 Codons of mutated amino acids are underlined. Mutated bases are shown in bold. 
2
 Forward and reverse primers to modify the N-terminus to MASMTGH6-.  
3 







Figure S1. 15N-HSQC spectra of 0.9 mM solutions of 15N-labelled WNV NS2B-
NS3pro(K96A) at 25 oC, pH 7.0, in the presence of (a) 3 mM 2 or (b) 3 mM 3. The 
backbone amide resonance assignments are indicated. 500 was added to NS2B sequence 
numbers to distinguish them from those of NS3pro. 
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Figure S2. Selected spectral region from 15N-HSQC spectra showing the effect of 
increasing concentrations of 2 on the NMR spectrum of WNV NS2B-NS3pro(K96A). 
The spectra were recorded at a 1H NMR frequency of 800 MHz, using a 0.8 mM protein 
solution in 20 mM HEPES buffer (pH 7.0) at 25 oC. The concentrations of 2 were 0.0 
(red), 0.3 (orange), 0.7 (green), and 1.5 mM (blue). The cross-peaks broadened 
significantly at intermediate titration ratios (orange spectrum). Increasing amounts of 2 
shift the cross-peak of Val166 high-field along the dotted line. In the absence of 2, it is 
broad due to conformational exchange in the protease (red spectrum) and it is below the 






N-HSQC spectra of combinatorially 
15
N-labelled samples of WNV NS2B-
NS3pro in the presence of 1. Each sample contained about 50 μM protease and 200 μM 
1  (t1max = 32 ms, t2max = 73 ms, Bruker 800 MHz NMR spectrometer). The five
 15
N-
HSQC spectra are superimposed, where each spectrum is of a sample containing a 
different set of 
15
N-labelled amino acids. Red: Leu, Arg, Asp, Asn, Tyr, His, Cys; 
yellow: Ala, Lys, Arg, Phe, Gln, Met, Cys, Trp; green: Gly, Ile, Lys, Thr, Asn, His, Trp; 
cyan: Ser, Val, Ile, Gln, Tyr, Met, His, Trp; magenta: Glu, Val, Thr, Asp, Phe, Met, 
Cys. The spectral region shown contains the most crowded region of the 
15
N-HSQC 






Figure S4. 800 MHz 1D 
1
H-NMR spectra of the compounds 2 and 3 in the absence and 
presence of WNV NS2B-NS3pro(K96A) in D2O solution containing 1.5% d6-DMSO. 
The d6-DMSO was used to dissolve the compounds and generated the resonance at 
about 2.7 ppm. (a) 0.5 mM 2. (b) 0.3 mM 3. (c) 0.6 mM 2 and 0.5 mM 3 in the presence 
of 30 μM WNV NS2B-NS3pro(K96A). The changes in chemical shifts compared to 
those in the absence of protease show that bound and free ligands are in fast exchange 




Figure S5. Superimposition of 
15
N-HSQC spectra of 0.3 mM WNV NS2B-
NS3pro(K96A) in the presence of 0.5 mM 3 (blue) and 0.2 mM 3 + 0.4 mM Bz-nKKR-
H (red). The peptide out-competes 3 by forming a covalent bond with the active-site 
serine (Yin et al., Bioorg Med Chem Lett 16, 40-43 (2006); Erbel et al., Nat Struct Mol 
Biol 13, 372-373 (2006)). The spectra were recorded under the same conditions as those 
of Figure 3. Boxes highlight cross-peaks of residues lining the binding pocket. NS2B 






Figure S6. Superimposition of 15N-HSQC spectra of 0.1 mM solutions of selectively 
15N-Gly labelled WNV NS2B-NS3pro(G151A) in the absence (red spectrum) and 
presence (black spectrum) of 0.2 mM 3. The spectra are indistinguishable, showing that 
the G151A mutation abolishes binding of 3. 
